All Type of News
MSD names new execs in shake-up
MSD Korea, the subsidiary of the U.S. pharmaceutical firm Merck & Co., Friday promoted Paik Chong-min, Quality Control manager as the head of Asia-Pacific quality control business units in a management reshuffle.
T...
CTCBIO to inject 64.5 billion won into vaccine projects
CTC Bio, a local biopharmaceutical company, said Friday it will inject 64.5 billion won, 14.38 percent of its stake, by December 30, 2013 into projects at expanding its manufacturing facilities for vaccines, injectabl...
Korean scientist focuses on cloning human stem cells
Professor Park Se-pill at Jeju National University is striving to clone human embryonic stem cells, the much-touted breakthrough that no scientists have ever achieved.
The embryologist has started cloning human emb...
Government urged to set up more R&D fund for drug companies
Korea needs to unveil a long-term vision to foster global pharmaceutical firms through the creation of a large-scale research and development (R&D) fund and offering various tax benefits to local companies, the countr...
Insurance fees to be raised for high income earners
Workers who earn additional income other than their employment wages are required to pay more in national health insurance fees, and the government should impose the same insurance premium rules to salaried workers an...
Pharmacy seeing revival
Recently, more and more television dramas are adding the ninth decade to their retro-reservoir, allowing celebrities who enjoyed their heyday two decades ago to return to the spotlight.
The release of “Architecture...
Concerns mounting over large drugstores
As Korea’s major retailers are charging into the drugstore business market, prompting concerns about further damage to small pharmacies that are already struggling to keep afloat.
Lotte and other large retailers h...
Yuhan teams up with Theragen Etex
Yuhan Corporation said Thursday it has signed a DNA sequencing service deal with Theragen Etex, a biopharmaceutical firm, in a move to help expand its presence in the domestic human genome service market.
Under the...
Nagoya protocol will hurt pharmaceutical sector
A report released on Wednesday said Korea's pharmaceutical sector could lose up to 200 billion won if a new treaty on the use of genetic resources goes through.
The estimated losses are based on an assumption that...
Tax breaks for R&D spending extended to 2015
Korea seeks to extend tax exemptions for pharmaceutical companies’ investment in research and development (R&D) to help create more jobs and investment in the face of cloudy economic conditions, the finance ministry s...
